A case of fulminant Type 1 diabetes associated with mexiletine hypersensitivity syndrome [3]

Diabetic Medicine

Volumn 21, Issue 10, 2004, Pages 1156-1157

  Seino, Y ^a   Yamauchi, M ^a   Hirai, C ^b   Okumura, A ^a   Kondo, K ^a   Yamamoto, M ^a   Okazaki, Y ^a  

^a ANJO KOSEI HOSPITAL   (Japan)

^b Hekinan Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; C PEPTIDE; GLUCOSE; INSULIN; MEXILETINE; PREDNISOLONE;

ADULT; CASE REPORT; DIABETES CONTROL; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; ELECTROPHYSIOLOGY; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; LETTER; MALE; MEXILETINE HYPERSENSITIVITY SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY;

ANTI-ARRHYTHMIA AGENTS; DIABETES MELLITUS, TYPE 1; DRUG HYPERSENSITIVITY; HUMANS; MALE; MEXILETINE; MIDDLE AGED;

EID: 6344277192     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01307.x     Document Type: Letter

References (8)

1. Tanaka S, Kobayashi T, Momotsu T. A novel subtype of type 1 diabetes mellitus. N Engl J Med 2000; 342: 1835-1837.
2. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med 2000; 342: 301-307.
3. Sekine N, Motokura T, Oki T, Umeda U, Sasaki N, Hayashi M et al. Rapid loss of insulin secretion in a patient with fulminant Type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome. JAMA 2001; 285: 1153-1154.
4. Sommers L, Schoene R. Alloputinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus. Arch Intern Med 2002; 162: 1190-1192.
5. Kim K, Kang Y, Choi S, Kim J, Kim H, Sun B et al. Modulation of glucocorticoid-induced GAD expression in pancreatic β-cells by transcriptional activation of the GAD 67 promoter and its possible effect on the development of diabetes. Diabetes 2002; 51: 2764-2772.
6. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998; 134: 1108-1112.
7. Tohyama M, Hashimoto K. Severe hypersensitivity syndrome to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol 1998; 134: 1117.
8. Tanaka S, Kobayashi T, Nakanishi K, Koyama R, Okubo M, Murase T et al. Association of HLA-DQ genotype in autoantibody-negative and rapid-onset type 1 diabetes. Diabetes Care 2002; 25: 2302-2307.